Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CAREN R., CORBO L. The potentiation of exogenous insulin by tolbutamide in depancreatized dogs. J Clin Invest. 1957 Nov;36(11):1546–1550. doi: 10.1172/JCI103551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- COLWELL A. R., Sr, COLWELL A. R., Jr, COLWELL J. A. Intrapancreatic perfusion of the antidiabetic sulfonylureas. Metabolism. 1956 Nov;5(6 Pt 2):749–756. [PubMed] [Google Scholar]
- DIENGOTT D., DOLGER H., MIRSKY I. A. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus. Metabolism. 1956 Nov;5(6 Pt 2):875–893. [PubMed] [Google Scholar]
- FRITZ I. B., LEVINE R., MORTON J. V., WEINSTEIN M. Studies on the mechanism of action of the sulfonylureas. Metabolism. 1956 Nov;5(6 Pt 2):744–748. [PubMed] [Google Scholar]
- GILBERTSEN A. S., GOETZ F. C., JOSEPHSON V. Acute effects of orinase on peripheral glucose utilization. Metabolism. 1956 Nov;5(6 Pt 2):788–800. [PubMed] [Google Scholar]
- HOUSSAY B. A., PENHOS J. C., URGOITI E., TEODOSIO N., APELBAUM J., BOWKETT J. The role of insulin in the action of the hypoglycemic sulfonyl compounds. Ann N Y Acad Sci. 1957 Jul 10;71(1):25–34. [PubMed] [Google Scholar]
- LOUBATIERES A. L'utilisation de certaines substances sulfamidées dans le traitement du diabète sucré expérimental; recherches personnelles (1942-1946). Presse Med. 1955 Dec 10;63(82):1701–1703. [PubMed] [Google Scholar]
- RICKETTS H. T., WILDBERGER H. L., SCHMID H. Long-term studies of the sulfonylureas in totally depancreatized dogs. Ann N Y Acad Sci. 1957 Jul 10;71(1):170–176. [PubMed] [Google Scholar]
- UNGER R. H. The standard two-hour oral glucose tolerance test in the diagnosis of diabetes mellitus in subjects without fasting hyperglycemia. Ann Intern Med. 1957 Dec;47(6):1138–1153. doi: 10.7326/0003-4819-47-6-1138. [DOI] [PubMed] [Google Scholar]